These stocks are likely to be in focus on March 4

These stocks are likely to be in focus on March 4

by 5paisa Research Team Last Updated: Mar 03, 2022, 05:50 PM IST

At market close on Thursday, the headline indices were down by 0.65%. The Sensex closed at 55,102.68 down by 366.22 points or 0.66 % and the Nifty was at 16,498.05 down by 107.90 points or 0.65%.

 On the BSE, 1981 shares have advanced, 1347 shares have declined, and 112 shares are unchanged.

These stocks are likely to be in focus for Friday's trading session:

Tata Consultancy Services Limited: Tata Consultancy Services has announced the launch of its Enterprise 5G Edge suite of solutions with Microsoft Azure private mobile edge computing (private MEC). The TCS suite brings together comprehensive capabilities that help enterprises design, integrate, implement, and operate an enterprise 5G edge ecosystem using the Azure private MEC solution and exploit the edge computing advantages for 5G applications. The scrip of TCS was at Rs 3402.25 on the BSE.

Reliance Industries Limited: Sanmina Corporation and Reliance Strategic Business Ventures Limited (RSBVL), a wholly-owned subsidiary of Reliance Industries Limited (RIL) announced that they have entered into an agreement to create a joint venture through investment in Sanmina’s existing Indian entity (Sanmina SCI India Private Ltd, “SIPL”). This partnership will leverage Sanmina’s advanced manufacturing experience and Reliance’s expertise and leadership in the Indian business ecosystem. The joint venture will create a world-class electronic manufacturing hub in India, in line with the Prime Minister's “Make in India” vision.

The shares of the company were down by 0.84% at Rs 2378.20 at market close on the BSE.

Lupin Limited: Global pharma major Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), Efinaconazole Topical Solution, 10% to market a generic equivalent of Jublia® Topical Solution, 10%, of Bausch Health Americas, Inc. The product will be manufactured at Lupin's facility in Pithampur, India. Efinaconazole Topical Solution, 10% (RLD: Jublia® Topical Solution, 10%) had estimated annual sales of USD 274 million in the U.S. (IQVIA MAT December 2021). The shares of Lupin were down by 1.12% at Rs 720.10 at market close on the BSE.

52-week high stocks: From the BSE 500 pack, the stocks of Hitachi energy, Adani Transmission, NALCO, Vedanta, and GNFC have hit their 52-week high on Thursday.

SENSEX
54,252.53
503.27 (0.94%)
Nifty 50
16,170.15
0.00 (0.00%)
Nifty Bank
35,094.90
0.00 (0.00%)
Next Article

Open Free Demat Account

& get benefits worth 5100*

 
Resend OTP
Please Enter OTP
  • Have Promo code?
  • Use code ACT5100
Enter Promo code

By proceeding, you agree to the T&C.

SENSEX
54,252.53
503.27 (0.94%)
Nifty 50
16,170.15
0.00 (0.00%)
Nifty Bank
35,094.90
0.00 (0.00%)

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number